135 related articles for article (PubMed ID: 9485558)
21. Comparison of two Bayesian approaches to dose-individualization for once-daily aminoglycoside regimens.
Duffull SB; Kirkpatrick CM; Begg EJ
Br J Clin Pharmacol; 1997 Feb; 43(2):125-35. PubMed ID: 9131944
[TBL] [Abstract][Full Text] [Related]
22. Impact of small-for-gestational age (SGA) status on gentamicin pharmacokinetics in neonates.
Lulic-Botica M; Sheer T; Edwards D; Thomas RL; Natarajan G
J Clin Pharmacol; 2014 Jan; 54(1):39-45. PubMed ID: 24122736
[TBL] [Abstract][Full Text] [Related]
23. The influence of weight with assay error on gentamicin pharmacokinetics using the Bayesian and nonlinear least square regression analysis in appendicitis patients.
Burm JP
Biopharm Drug Dispos; 2005 Jul; 26(5):189-94. PubMed ID: 15906419
[TBL] [Abstract][Full Text] [Related]
24. Comparison of creatinine clearance estimation methods in patients with trauma.
Davis GA; Chandler MH
Am J Health Syst Pharm; 1996 May; 53(9):1028-32. PubMed ID: 8744465
[TBL] [Abstract][Full Text] [Related]
25. Population pharmacokinetics of gentamicin in preterm neonates: evaluation of a once-daily dosage regimen.
Vervelde ML; Rademaker CM; Krediet TG; Fleer A; van Asten P; van Dijk A
Ther Drug Monit; 1999 Oct; 21(5):514-9. PubMed ID: 10519447
[TBL] [Abstract][Full Text] [Related]
26. Gentamicin pharmacokinetics in Thai neonates: recommendation for a dosing guideline.
Kanthawatana S; Uruwannakul K; Chotinarumon S
J Med Assoc Thai; 1998 Feb; 81(2):136-40. PubMed ID: 9529844
[TBL] [Abstract][Full Text] [Related]
27. Validation of a dosage individualization table for extended-interval gentamicin in neonates.
Dersch-Mills D; Akierman A; Alshaikh B; Yusuf K
Ann Pharmacother; 2012; 46(7-8):935-42. PubMed ID: 22739714
[TBL] [Abstract][Full Text] [Related]
28. Once-daily gentamicin dosing in children with febrile neutropenia resulting from antineoplastic therapy.
Inparajah M; Wong C; Sibbald C; Boodhan S; Atenafu EG; Naqvi A; Dupuis LL
Pharmacotherapy; 2010 Jan; 30(1):43-51. PubMed ID: 20030472
[TBL] [Abstract][Full Text] [Related]
29. Aminoglycoside Dosing and Volume of Distribution in Critically Ill Surgery Patients.
Grucz TM; Kruer RM; Bernice F; Lipsett PA; Dorman T; Sugrue D; Jarrell AS
Surg Infect (Larchmt); 2020 Dec; 21(10):859-864. PubMed ID: 32302517
[No Abstract] [Full Text] [Related]
30. Pharmacokinetics of once-daily gentamicin dosing in pediatric patients.
Bass KD; Larkin SE; Paap C; Haase GM
J Pediatr Surg; 1998 Jul; 33(7):1104-7. PubMed ID: 9694103
[TBL] [Abstract][Full Text] [Related]
31. Creatinine-clearance estimates for predicting gentamicin pharmacokinetic values in obese patients.
Leader WG; Tsubaki T; Chandler MH
Am J Hosp Pharm; 1994 Sep; 51(17):2125-30. PubMed ID: 7985687
[TBL] [Abstract][Full Text] [Related]
32. Population pharmacokinetics of gentamicin in horses.
Martín-Jiménez T; Papich MG; Riviere JE
Am J Vet Res; 1998 Dec; 59(12):1589-98. PubMed ID: 9858412
[TBL] [Abstract][Full Text] [Related]
33. Use of 4-mg/kg/24-hour empiric aminoglycoside dosing in preoperative neonates with congenital heart disease.
Moffett BS; Rossano JW
Ann Pharmacother; 2012 Sep; 46(9):1193-7. PubMed ID: 22911340
[TBL] [Abstract][Full Text] [Related]
34. The effects of age and chemotherapy on gentamicin pharmacokinetics and dosing in pediatric oncology patients.
Ho KK; Bryson SM; Thiessen JJ; Greenberg ML; Einarson TR; Leson CL
Pharmacotherapy; 1995; 15(6):754-64. PubMed ID: 8602384
[TBL] [Abstract][Full Text] [Related]
35. Validation of the Hartford nomogram in trauma surgery patients.
Finnell DL; Davis GA; Cropp CD; Ensom MH
Ann Pharmacother; 1998 Apr; 32(4):417-21. PubMed ID: 9562135
[TBL] [Abstract][Full Text] [Related]
36. Quantitative justification for target concentration intervention--parameter variability and predictive performance using population pharmacokinetic models for aminoglycosides.
Matthews I; Kirkpatrick C; Holford N
Br J Clin Pharmacol; 2004 Jul; 58(1):8-19. PubMed ID: 15206987
[TBL] [Abstract][Full Text] [Related]
37. Use of a common spreadsheet program to demonstrate the ability of Bayesian forecasting to estimate the pharmacokinetic parameters of antibiotics.
Brocks DR; Wang M
J Pharm Pharmacol; 2023 Oct; 75(10):1378-1387. PubMed ID: 37478874
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of six gentamicin nomograms using a bayesian parameter estimation program.
Thomson AH; Campbell KC; Kelman AW
Ther Drug Monit; 1990 May; 12(3):258-63. PubMed ID: 2349609
[TBL] [Abstract][Full Text] [Related]
39. Augmented renal clearance of aminoglycosides using population-based pharmacokinetic modelling with Bayesian estimation in the paediatric ICU.
Avedissian SN; Rhodes NJ; Kim Y; Bradley J; Valdez JL; Le J
J Antimicrob Chemother; 2020 Jan; 75(1):162-169. PubMed ID: 31648297
[TBL] [Abstract][Full Text] [Related]
40. The "Ideal" Body Weight for Pediatric Gentamicin Dosing in the Era of Obesity: A Population Pharmacokinetic Analysis.
Moffett BS; Kam C; Galati M; Schmees L; Stitt GA; Revell PA; Palazzi DL
Ther Drug Monit; 2018 Jun; 40(3):322-329. PubMed ID: 29521784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
